Purpose. The standard culture findings for detecting and identifying bacterial pathogens in patients with lower respiratory tract infections (LRTIs) are usually not available for two to three days, which delays the initiation of appropriate antibiotic therapies. We aimed to develop a faster method of identification of bacterial pathogens in LRTIs which would offer a timelier guide to initial antibiotic choices.
INTRODUCTION
The most common infections that lead to morbidity and mortality worldwide are lower respiratory tract infections (LRTIs). Approximately one-third of cases are caused by bacteria, including acute bronchitis, chronic bronchitis, otitis media, sinusitis, and pneumonia. The remainder is caused by pathogenic viruses. Previous studies have shown that despite the higher incidence of viral LRTIs, >80 % LRTI patients were administered antibiotics, which are not effective against viral infections, during initial therapy [1, 2] . Antibiotic misuse has resulted in increased drug resistance and a series of other side effects [3] . Therefore, to treat LRTIs promptly, specifically, and effectively, the early recognition and accurate diagnosis of microbial etiology are essential. The gold standard for detecting microorganisms in sputum samples is based on colony morphology and conventional biochemical confirmation tests of the cultured bacteria [4, 5] . Unfortunately, phenotypic identification by culture requires a minimum of two to three days to complete and an additional day to perform susceptibility testing. A faster method to classify microorganisms directly from sputum would allow the tailoring of empirical antibiotic therapy and reduce a patient's exposure to ineffective or unnecessary antibiotics while awaiting susceptibility testing results.
Sequence-based identification of the PCR amplicons of the ribosomal RNA (rRNA) genes has proved useful for identifying many different microorganisms and has become common practice in the clinical laboratories. Pyrosequencing, a new generation of DNA sequencing technology, does not require electrophoresis or fluorescent labeling of the target DNA fragment. The prominent feature of pyrosequencing is the rapid and accurate analysis of short DNA sequences with a high throughput capacity, making it very attractive for the identification and genotyping of microorganisms. Several investigators have used pyrosequencing to identify bacteria, yeasts, or fungi [6, 7] . In practice, a relatively short sequence is sufficient for bacteria identification [4, 8, 9] .
Here, we used PCR and pyrosequencing targeting the 16S rRNA gene to identify bacteria directly from sputum and compared the results with those obtained via the conventional culture-based method. We also developed a new method that we designated mask PCR-pyrosequencing (MPP), which reduces the interference from colonised Veillonella spp., Neisseria meningitidis, Rothia dentocariosa, and Streptococcus viridans in sputum samples and compared it with previously described PCR and pyrosequencing methods.
METHODS

Sample collection
A total of 263 sputum specimens were collected from Sir Run Run Shaw Hospital of Zhejiang University, China, between January and May 2018. Including 44 bronchial infection cases (average age of 67.2±11.5 SD years), 14 females and 30 males; 178 community-acquired pneumonia (CAP) cases (average age of 63.4±17.7 SD years), 54 females and 124 males; 15 chronic obstructive pulmonary disease (COPD) cases (average age of 72.4±4.7 SD years), three females and 12 males; 24 acute exacerbations of COPD (AE-COPD) cases (average age of 77.3±6.4 SD years), six females and 18 males; two ventilator-associated pneumonia (VAP) cases, ages 67 and 72, all males. Sputum validity was assessed according to the Geckler criteria. Samples containing <10 squamous epithelial cells and >25 white blood cells, or where the ratio of squamous epithelial cells : white blood cells was <1 : 2.5 per low-power microscope field were accepted [10] .
Sputum culture and standard bacteria identification For every specimen, a semi-quantitative culture was performed within 2 h of sample collection using the four quadrant streak technique with a 5 µl calibrated loop. The sputum cultures were read semi-quantitatively and graded as 1+, 2+, 3+ or 4+ by observing the growth in the four quadrants, which indicate the approximate number of colony-forming units per milliliter (c.f.u ml ) growth of a predominant bacterium in a sputum culture was considered a presumptive pathogen [11, 12] . The cultured bacterial colonies were identified according to standard methods based on colonial morphology, Gram staining, and oxidase production. The suspected infectious colonies were further separated for pure culture and identified using the VITEK 2 Compact system (bioM erieux).
Sputum digestion
After streaking for culture, the remaining sputum was digested according to the procedure described by Kent and Kubica and recommended by the Centers for Disease Control (CDC) and the World Health Organization (WHO)/ International Union Against Tuberculosis and Lung Disease [13, 14] . Specifically, an approximately equal volume of solution containing 0.5 % (w/v) N-acetyl-L-cysteine, 2.67 % (w/v) NaOH, and 1.45 % (w/v) sodium citrate was added to the sputum, and the mixture was incubated at room temperature for 15 min. Then, 1 ml of the liquefied mixture was pipetted into a 1.5 ml microcentrifuge tube and centrifuged at 12 000 g for 5 min. The resultant pellet was washed by resuspending in 1 ml PBS and further centrifugation.
DNA extraction
A volume of 100 µl lysis buffer (1 % Tween-20, 1 % NP-40, 0.03 % SDS, 5 % Chelex, and 400 µg ml À1 protease K) was added to the sediment above and vortexed thoroughly to mix well. The mixture was incubated at 56 C for 15 min, followed by 100 C for 10 min. The lysate was then centrifuged at 13 000 g for 5 min. The supernatant was used as the DNA template for subsequent PCR assays.
PCR
For each sputum specimen, two types of PCR reactions were performed: normal PCR and masked PCR. All PCR reagents were purchased from MBI Fermentas (Amherst, USA), and the primers were synthesised by Invitrogen (Shanghai, PR China). The primer sequences used in each PCR reaction are described in Table 1 .
The normal PCR reactions contained 3 µl of template DNA, 5 µl 10ÂPCR buffer, 1.5 U Hot start Taq DNA polymerase, 0.2 mM dNTP mixture, 2 mM MgCl 2 , and 0.06 µM each of forward (VF) and reverse primer (VR) in a final volume of 50 µl. The PCR conditions were 1 cycle of 3 min at 95 C; followed by 35 cycles of 94 C for 25 s, 52 C for 30 s, and 72 C for 20 s; and a final extension at 72 C for 3 min.
MPP is based on competitive PCR. Four reverse primers specific for each of Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans were designed according to the following criteria: (i) the primers were specific for sequences unique to each of Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans; (ii) the 5¢ primer regions overlapped by more than three bases with the 3¢ region of the general reverse primers; and (iii) the melting temperature (T m ) of the specific primers was 5 -10 higher than that of the general primers. The general reverse primer was biotinylated, and the specific reverse primers were not. When PCR was conducted with the general forward primer, the general reverse primer, and the four reverse primers in a single tube, specific PCR products of Veillonella spp., N. meningitidis, R. dentocariosa, S. viridans and PCR products of other bacteria that were present in the sputum sample were generated. The PCR products of Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans were then washed away during the single-strand purification procedure, and the remaining PCR products of the pathogenic bacteria were pyrosequenced.
The mask PCR reactions contained 3 µl of template DNA, 5 µl 10ÂPCR buffer, 2 U Taq DNA polymerase, 0.4 mM dNTP mixture, 2 mM MgCl 2 , 0.2 µM forward primer (VF), 0.06 µM reverse primer (VR), and 1.6 µM of each mask primer (MP1-MP4) in a final volume of 50 µl. The PCR conditions were the same as for normal PCR.
Pyrosequencing
Pyrosequencing was performed on a PyroMark Q96 ID platform (Qiagen) as per the manufacturer's instructions. Briefly, 50 µl of amplified DNA product was mixed with 3 µl of streptavidin-sepharose beads (Amersham Biosciences) and shaken at 2000 r.p.m. for 10 min to immobilise the biotinylated DNA. The double-stranded DNA was separated in a denaturing buffer (0.2 M NaOH) using a vacuum prep tool (Qiagen). Then, the single-stranded DNA was annealed with 0.5 µl sequencing primer (S in Table 1 ) in an annealing buffer (Qiagen) at 80 C for 2 min. The processed mixture was loaded onto the PyroMark Q96 ID system equipped with PyroMark Q96 ID software 2.5 (Qiagen) for pyrosequencing set with a cyclic dispensation order of ATCG. The resultant sequences were generated and automatically analysed using PSQ 96 SQA software (Qiagen).
Bacterial identification database construction
A database that contained sequences generated by the pyrosequencing of single and multiple bacterial infections was created. It included >300 of the most common bacterial species with an established clinical significance [15] . All of the sequences used to construct the database were derived from GenBank (http://www.ncbi.nlm.nih.gov/). Following pyrosequencing, the results were compared with that of the database, and those with a 100 % DNA sequence match to an organism in the database were accepted as the identification results.
Sensitivity test of the pyrosequencing method
A sensitivity test of the pyrosequencing system for bacterial detection and identification in sputum specimens was conducted by mixing serial dilutions of the cultured bacterial colonies with sputum specimens. Briefly, a suspension of the bacterial colonies was prepared to a 0.5 McFarland turbidity standard, equivalent to 1.5Â10 8 c.f.u ml
À1
. Then, 10-fold serial dilutions of 1.5Â10 7 , 1.5Â10 6 , and 1.5Â10 5 c.f.u ml À1 were made. For each concentration, 667 µl of the bacterial suspension was pipetted into a 1.5 ml microcentrifuge tube and centrifuged at 12 000 g for 5 min. Pre-digested sputum (1 ml) from a healthy individual was added to the sediment, and bacterial DNA was extracted as described above. Then, NPP and MPP were performed as described above.
Several classical bacterial colonies were tested including Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
RESULTS
Semi-quantitative culture and normal PCRpyrosequencing Table 2 shows the pathogen test results of the 263 sputum specimens that were identified with the standard culture method and the pyrosequencing method. The standard sputum culture results combined with the automated identification system identified a total of 157 pathogenic bacterial strains from 148 specimens, giving a positive rate of 56.3 %, and the other 115 samples did not exhibit any growth. Among the 157 pathogenic strains detected, the semi-quantitative culture results revealed 14 strains of 10 5 c.f.u ml À1 , 89 strains of 10 6 c.f.u ml
À1
, and 54 strains of 10 7 c.f.u ml , and 54 of 54 strains of 10 7 c.f.u ml
. Among the pathogens identified by the two methods, P. aeruginosa was the most common, accounting for 28.0 % by culture and 22.3 % by pyrosequencing. The next most common was K. pneumoniae, accounting for 27.4 % by culture and 21.8 % by pyrosequencing.
The identification results were coincident in 81.0 % (213 of 263) cases by culture and NPP. The samples with different identification results were classified into five groups (Table 3) . Those in group A were positive by both culture and NPP, but a different species were identified (2.7 %). Group B samples were negative by culture but positive by NPP (3.4 %), comprising Haemophilus spp. Group C isolates were positive for Veillonella spp. or R. dentocariosa by NPP and positive for other bacterial pathogens by culture (3.8 %). Group D isolates were negative by culture but positive for Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans by NPP (10.6 %). The members of group E were positive by culture but negative by NPP (2.3 %).
MPP
MPP was conducted because of the interference from colonised Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans exhibited in the NPP results for some of the specimens tested. The coincidence of identification results of culture and MPP reached 91.3 % (240 of 263), which was higher than that of NPP (81.0 %, 213 of 263). Two factors were attributed to making the greatest contribution to the increased accuracy. Firstly, the cases identified as Veillonella parvula (7 of 263), N. meningitidis (1 of 263), R. dentocariosa (8 of 263), and S. viridans (2 of 263) by NPP were identified as normal bacteria by MPP. Secondly, for 90 % (9 of 10) group C cases where different identification results between culture and NPP were observed, the results by MPP agreed with those by culture, The only exception is one case which was identified as P. aeruginosa by culture method but identified as R. dentocariosaby NPP, MPP failed to identify it correctly due to low pathogen concentration.
Sensitivity of PCR-pyrosequencing
When the bacterial pathogen in sputum reached 1.0Â10 7 c.f.u ml
À1
, a specific bacterial pyrogram could be generated, and a specific identification could be made by searching for sequence homology in the constructed database. The sputum containing bacteria at 1.0Â10 6 c.f.u ml À1 or lower generated nonspecific pyrograms, and we were unable to obtain specific identification results. Therefore, the detection . No significant differences in the detection threshold between NPP and MPP were observed.
DISCUSSION
Compared with bronchoalveolar lavage and protected specimen brush samples, sputum was better accepted by patients as the specimen for the diagnosis of LRTIs because it was easy to obtain and noninvasive. Currently, sputum culture and subsequent biochemistry reactions are considered the gold standard to detect and identify bacterial pathogens of LRTIs. However, the process takes two to three days, and bacteria such as Burkholderia cepacia, which are difficult to grow under laboratory conditions, take even longer to culture or do not grow at all [16, 17] . Therefore, a rapid, accurate, and reliable technology for detecting and identifying bacterial pathogens in LRTIs utilising sputum specimens would be of great significance to LTRI treatment.
The detection of pathogens directly from a clinical specimen via PCR has many advantages compared with the traditional culture and biochemistry methods [18] . In this study, the PCR-pyrosequencing method used for the detection and identification of bacterial pathogens directly from sputum specimens was based on the identification of 16S rRNA bacterial genes. A 60 bp DNA fragment was amplified with general primers, followed by pyrosequencing with a sequencing primer. The sequence generated was compared with the constructed bacterial sequence database to achieve the identification result. This identification procedure took only 5 h from start to finish, greatly reducing the identification time. In our test of 263 clinical sputum specimens, the results of this method exhibited a high coincidence with the identification results obtained using the standard culture method (81 % by NPP, 91.3 % by MPP).
A commonly overlooked problem associated with the sputum culture method is the uneven pathogen distribution within the specimen. This may produce results that do not truly reflect the microbial etiology in vivo [19] . In the pyrosequencing method, however, liquefaction of the entire sputum specimen is performed prior to DNA extraction. Thus, these results are more reliable. In fact, this may be the reason for the difference between the two methods in group A. The uneven distribution of pathogens in sputum specimens could explain why Escherichia coli was identified by culture, but K. pneumoniae was identified by pyrosequencing. During the streaking process, the calibrated loop might have streaked a portion of sputum that was rich in E. coli, even though K. pneumoniae was actually predominant.
A great challenge for LRTI diagnosis utilising sputum culture is the contamination by colonised floras of the oropharynx and upper respiratory tract. A previous study determined that organisms colonise the oropharynx in the order of 10 6 c.f.u ml À1 , which markedly confounded the analysed data [1] . Since 10 6 c.f.u ml À1 is also the lower sensitivity limit of the pyrosequencing method, colonised bacteria at this level resulted in unidentifiable pyrograms as a result of mixed sequences of colonised and pathogenic bacteria. Therefore, only when the pathogens in a sputum specimen reach or exceed 1.0Â10 7 c.f.u ml À1 could they be specifically detected and identified by pyrosequencing.
We do not believe the relatively low sensitivity of the pyrosequencing method will limit its application in clinical practice. Bacteria with a low concentration isolated by sputum culture may be the result of contamination by colonised bacteria in the upper respiratory tract or oropharynx. The quantitative sputum culture could distinguish pathogens from contaminating bacteria, and only bacteria exhibiting a heavy growth of grade 4+ (corresponding to 1.0Â10 7 c.f.u ml
À1
) are considered a pathogen [20] . The sensitivity of the pyrosequencing method for detecting pathogens in sputum specimens in this study was 1.0Â10 6 -1.0Â10 7 c.f.u ml
. In this study of clinical specimens, NPP identified 28.6 % strains of grade 2+, 89.9 % of grade 3+, and 100 % of grade 4+. Therefore, the pyrosequencing method is sufficiently sensitive for the detection of pathogens in sputum specimens in clinical practice. Moreover, it can effectively exclude the contaminating bacteria that are commonly encountered with standard sputum culture techniques.
We discovered that in some cases, Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans greatly interfered with the NPP identification result (10.6 %, 28 of 263). Because of the predomination of these bacteria in the sputum, the pathogen concentration was relatively low. Thus, Veillonella spp., N. meningitidis, R. dentocariosa, and S. viridans were identified, but the pathogen escaped detection. To solve this problem, we developed MPP. Compared with NPP, MPP increased the identification accuracy of grade 3+ strains from 89.9 % (80 of 89) to 98.9 % (88 of 89), that is, MPP was superior to NPP. Sometimes, colonised floras in the oropharynx and upper respiratory tract differ according to regions, and mask primers could be designed accordingly by following the criteria described above and introduced into the mask PCR system. This could greatly increase the applicability of the MPP system for the detection of pathogenic bacteria in LRTIs.
Another advantage of a pyrosequencing identification method is that it is capable of the detection and identification of more than two pathogens in a single reaction. However, several problems with this approach might prevent it from becoming a routine diagnostic tool. Firstly, shared sequences between closely related bacteria may make them difficult to distinguish. This, however, will not greatly affect its clinical application because bacteria with the same 16S rRNA gene sequence could be further distinguished with a different DNA fragment such as a portion of the 23S rRNA gene [21] . Secondly, when a specimen contains two or more different pathogens and one is significantly higher in concentration than the others (>10 fold), the identification result will only reveal the predominant pathogen because of the amplification bias of PCR.
In summary, using clinical samples, we demonstrated the speed, accuracy, and high throughput of the pyrosequencing method for detecting and identifying pathogens in sputum. With these attractive features, this method might be used for the routine identification of pathogens in LRTI patients in the future.
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